Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization

This retrospective study presents data from 105 consecutive multiple myeloma and lymphoma patients who had PB CD34+ cell counts

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2015-01, Vol.50 (1), p.34-39
Hauptverfasser:	Sánchez-Ortega, I, Querol, S, Encuentra, M, Ortega, S, Serra, A, Sanchez-Villegas, J M, Grifols, J R, Pujol-Balaguer, M M, Pujol-Bosch, M, Martí, J M, Garcia-Cerecedo, T, Barba, P, Sancho, J M, Esquirol, A, Sierra, J, Duarte, R F
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308 Adult Aged Anti-HIV agents Anti-HIV Agents - administration & dosage Antigens, CD34 - blood Autografts Bone marrow Care and treatment Cell Biology Comparative analysis Dosage and administration Drug therapy Female Granulocyte Colony-Stimulating Factor - administration & dosage Hematology Hematopoietic Stem Cell Mobilization Heterocyclic Compounds - administration & dosage Humans Internal Medicine Leukocyte Count Lymphoma - blood Lymphoma - therapy Lymphomas Male Medicine Medicine & Public Health Middle Aged Multiple myeloma Multiple Myeloma - blood Multiple Myeloma - therapy original-article Peripheral Blood Stem Cell Transplantation Plerixafor Public Health Risk Factors Stem cell transplantation Stem Cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This retrospective study presents data from 105 consecutive multiple myeloma and lymphoma patients who had PB CD34+ cell counts
ISSN:	0268-3369 1476-5365
DOI:	10.1038/bmt.2014.196